Breaking News Instant updates and real-time market news.

LLY

Eli Lilly

$146.57 /

-0.72 (-0.49%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

05:42
02/10/20
02/10
05:42
02/10/20
05:42

Eli Lilly says DIAN-TU Study of solanezumab did not meet primary endpoint

Eli Lilly (LLY) announced that the analysis performed by Washington University School of Medicine in the Dominantly Inherited Alzheimer Network Trials Unit, or DIAN-TU, Study showed that solanezumab did not meet the primary endpoint. Additional analyses of secondary endpoints and biomarkers are ongoing by Washington University and Lilly. Results will be presented at the Advances in Alzheimer's and Parkinson's Therapies, or AAT-AD/PD, Focus Meeting in April of 2020. At this time, Lilly does not plan to pursue a submission for solanezumab in people with dominantly inherited Alzheimer's disease, or DIAD, also known as autosomal dominant Alzheimer's disease, based on the result of the primary endpoint. This outcome does not impact the ongoing solanezumab Anti-Amyloid Treatment in Asymptomatic Alzheimer's Study. The DIAN-TU Study, which was established in 2010 and funded by Lilly, Roche and Genentech (RHHBY), National Institutes of Health, and other donors, is the first disease prevention trial to test investigational Alzheimer's disease compounds with different mechanisms of action from two pharmaceutical companies. The collaboration between Lilly, Washington University, Roche and Genentech combined research, resources, and expertise for a common goal of serving patients and their loved ones battling this devastating disease.

LLY

Eli Lilly

$146.57 /

-0.72 (-0.49%)

RHHBY

Roche

$0.00 /

+ (+0.00%)

  • 10

    Feb

  • 10

    Feb

  • 24

    Feb

  • 06

    Mar

  • 06

    Apr

  • 23

    Apr

LLY Eli Lilly
$146.57 /

-0.72 (-0.49%)

02/05/20 Mizuho
Eli Lilly initiated with a Neutral at Mizuho
02/05/20 Mizuho
Eli Lilly initiated with a Neutral at Mizuho
01/23/20 H.C. Wainwright
Dermira downgraded to Neutral from Buy at H.C. Wainwright
01/13/20 Piper Sandler
Partnership termination not a negative for NextCure N318, says Piper Sandler
RHHBY Roche
$0.00 /

+ (+0.00%)

01/23/20 Cantor Fitzgerald
PTC Therapeutics price target raised to $81 from $60 at Cantor Fitzgerald
12/30/19 William Blair
William Blair says Wave 'disappointment' leaves Ionis, Roche in Huntington lead
12/26/19 Citi
Sarepta partnership comes with attractive economics, says Citi
12/24/19 Credit Suisse
Sarepta price target lowered to $185 from $190 at Credit Suisse

TODAY'S FREE FLY STORIES

Recommendations
Chart Industries price target raised to $50 from $43 at Citi » 06:40
06/02/20
06/02
06:40
06/02/20
06:40
GTLS

Chart Industries

$41.09 /

+1.87 (+4.77%)

Citi analyst J.B. Lowe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GTLS Chart Industries
$41.09 /

+1.87 (+4.77%)

GTLS Chart Industries
$41.09 /

+1.87 (+4.77%)

04/28/20 Citi
Chart Industries expanding margins despite headwinds, says Citi
04/23/20 Stifel
Chart Industries seems to be faring 'much better' than feared, says Stifel
04/09/20 Lake Street
Chart Industries price target lowered to $59 from $109 at Lake Street
03/09/20 Citi
Citi downgrades nine oilfield services names 'until dust settles' in oil market
GTLS Chart Industries
$41.09 /

+1.87 (+4.77%)

Recommendations
Canada Goose wholesale disruption largely priced in, says RBC Capital » 06:40
06/02/20
06/02
06:40
06/02/20
06:40
GOOS

Canada Goose

$20.71 /

+1.27 (+6.53%)

RBC Capital analyst Kate…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOOS Canada Goose
$20.71 /

+1.27 (+6.53%)

GOOS Canada Goose
$20.71 /

+1.27 (+6.53%)

05/15/20 BofA
Canada Goose downgraded to Underperform from Neutral at BofA
05/15/20 BofA
Canada Goose downgraded to Underperform from Neutral at BofA
04/28/20 BTIG
Canada Goose initiated with a Buy at BTIG
04/15/20 CIBC
Canada Goose price target lowered to C$35 from C$57 at CIBC
GOOS Canada Goose
$20.71 /

+1.27 (+6.53%)

GOOS Canada Goose
$20.71 /

+1.27 (+6.53%)

GOOS Canada Goose
$20.71 /

+1.27 (+6.53%)

GOOS Canada Goose
$20.71 /

+1.27 (+6.53%)

Recommendations
MacroGenics price target raised to $25 from $15 at Citi » 06:39
06/02/20
06/02
06:39
06/02/20
06:39
MGNX

MacroGenics

$21.10 /

+1.87 (+9.72%)

Citi analyst Yigal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MGNX MacroGenics
$21.10 /

+1.87 (+9.72%)

MGNX MacroGenics
$21.10 /

+1.87 (+9.72%)

06/01/20 Guggenheim
Guggenheim upgrades MacroGenics to Buy on pipeline prospects
06/01/20 Guggenheim
MacroGenics upgraded to Buy from Neutral at Guggenheim
05/29/20 Stifel
MacroGenics price target raised to $36 from $21 at Stifel
05/28/20 BTIG
MacroGenics price target raised to $35 from $23 at BTIG
MGNX MacroGenics
$21.10 /

+1.87 (+9.72%)

MGNX MacroGenics
$21.10 /

+1.87 (+9.72%)

Recommendations
Arcus Biosciences price target raised to $41 from $15 at Citi » 06:37
06/02/20
06/02
06:37
06/02/20
06:37
RCUS

Arcus Biosciences

$33.10 /

+1.63 (+5.18%)

, GILD

Gilead

$75.15 /

-2.64 (-3.39%)

Citi analyst Yigal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCUS Arcus Biosciences
$33.10 /

+1.63 (+5.18%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

RCUS Arcus Biosciences
$33.10 /

+1.63 (+5.18%)

05/27/20 Raymond James
Raymond James keeps Market Perform on Gilead following Arcus partnership
05/27/20 Wedbush
Arcus Biosciences price target raised to $48 from $40 at Wedbush
05/27/20 Piper Sandler
Piper says partnership more favorable for Gilead than outright Arcus purchase
05/14/20 Mizuho
Arcus Biosciences price target raised to $40 from $22 at Mizuho
GILD Gilead
$75.15 /

-2.64 (-3.39%)

06/01/20 Piper Sandler
Remdesivir now proven effective for COVID-19 in three studies, says Piper
05/27/20 Raymond James
Raymond James keeps Market Perform on Gilead following Arcus partnership
05/27/20 Wedbush
Arcus Biosciences price target raised to $48 from $40 at Wedbush
05/27/20 Piper Sandler
Piper says partnership more favorable for Gilead than outright Arcus purchase
RCUS Arcus Biosciences
$33.10 /

+1.63 (+5.18%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

RCUS Arcus Biosciences
$33.10 /

+1.63 (+5.18%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

RCUS Arcus Biosciences
$33.10 /

+1.63 (+5.18%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

RCUS Arcus Biosciences
$33.10 /

+1.63 (+5.18%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

Downgrade
Iterum Therapeutics downgraded to Sector Perform from Outperform at RBC Capital » 06:36
06/02/20
06/02
06:36
06/02/20
06:36
ITRM

Iterum Therapeutics

$1.70 /

-2.53 (-59.81%)

RBC Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ITRM Iterum Therapeutics
$1.70 /

-2.53 (-59.81%)

ITRM Iterum Therapeutics
$1.70 /

-2.53 (-59.81%)

01/21/20 Gabelli
Iterum Therapeutics downgraded to Sell from Buy at Gabelli
12/11/19 RBC Capital
Iterum Therapeutics price target lowered to $10 from $14 at RBC Capital
12/11/19 SVB Leerink
Iterum Therapeutics downgraded to Market Perform from Outperform at SVB Leerink
06/21/19 H.C. Wainwright
Iterum Therapeutics initiated with a Buy at H.C. Wainwright
ITRM Iterum Therapeutics
$1.70 /

-2.53 (-59.81%)

Downgrade
1-800-Flowers.com downgraded to Underperform from Neutral at DA Davidson » 06:36
06/02/20
06/02
06:36
06/02/20
06:36
FLWS

1-800-Flowers.com

$22.81 /

+0.64 (+2.89%)

DA Davidson analyst Linda…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLWS 1-800-Flowers.com
$22.81 /

+0.64 (+2.89%)

FLWS 1-800-Flowers.com
$22.81 /

+0.64 (+2.89%)

04/13/20 DA Davidson
1-800-Flowers.com downgraded to Neutral from Buy at DA Davidson
04/13/20 DA Davidson
1-800-Flowers.com downgraded to Neutral from Buy at DA Davidson
01/24/20 Northcoast
1-800-Flowers.com upgraded to Buy from Neutral at Northcoast
01/06/20 Benchmark
Benchmark names Alibaba, Nvidia, Comcast among best ideas for first half
FLWS 1-800-Flowers.com
$22.81 /

+0.64 (+2.89%)

FLWS 1-800-Flowers.com
$22.81 /

+0.64 (+2.89%)

Upgrade
Gordon Haskett upgrades Lowe's to Buy, sees continued home investment » 06:35
06/02/20
06/02
06:35
06/02/20
06:35
LOW

Lowe's

$129.36 /

-0.89 (-0.68%)

, HD

Home Depot

$247.24 /

-1.77 (-0.71%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LOW Lowe's
$129.36 /

-0.89 (-0.68%)

HD Home Depot
$247.24 /

-1.77 (-0.71%)

LOW Lowe's
$129.36 /

-0.89 (-0.68%)

06:07 Today Gordon Haskett
Lowe's upgraded to Buy from Hold at Gordon Haskett
05/22/20 Longbow
Lowe's price target raised to $150 from $130 at Longbow
05/21/20
Fly Intel: Top five analyst upgrades
05/21/20 Loop Capital
Lowe's price target raised to $140 from $105 at Loop Capital
HD Home Depot
$247.24 /

-1.77 (-0.71%)

05/21/20 Bernstein
Walmart built for crisis, investing despite uncertainty, says Bernstein
05/20/20 Stifel
Lowe's upgraded to Buy from Hold at Stifel
05/20/20 Loop Capital
Home Depot price target raised to $265 from $235 at Loop Capital
05/20/20 Credit Suisse
Home Depot price target raised to $255 from $215 at Credit Suisse
LOW Lowe's
$129.36 /

-0.89 (-0.68%)

HD Home Depot
$247.24 /

-1.77 (-0.71%)

HD Home Depot
$247.24 /

-1.77 (-0.71%)

LOW Lowe's
$129.36 /

-0.89 (-0.68%)

HD Home Depot
$247.24 /

-1.77 (-0.71%)

LOW Lowe's
$129.36 /

-0.89 (-0.68%)

HD Home Depot
$247.24 /

-1.77 (-0.71%)

Upgrade
Hess Corp. upgraded to Buy from Neutral at Citi » 06:34
06/02/20
06/02
06:34
06/02/20
06:34
HES

Hess Corp.

$48.70 /

+1.2 (+2.53%)

Citi analyst Scott Gruber…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HES Hess Corp.
$48.70 /

+1.2 (+2.53%)

HES Hess Corp.
$48.70 /

+1.2 (+2.53%)

06/01/20 JPMorgan
JPMorgan upgrades Hess to Overweight on next upcycle positioning
06/01/20 JPMorgan
Hess Corp. upgraded to Overweight from Neutral at JPMorgan
05/08/20 Susquehanna
Hess Corp. price target raised to $54 from $45 at Susquehanna
03/20/20 Stephens
Stephens upgrades Hess, downgrades 11 others in E&P following oil's melt down
HES Hess Corp.
$48.70 /

+1.2 (+2.53%)

HES Hess Corp.
$48.70 /

+1.2 (+2.53%)

HES Hess Corp.
$48.70 /

+1.2 (+2.53%)

HES Hess Corp.
$48.70 /

+1.2 (+2.53%)

Downgrade
Western Alliance downgraded to Equal Weight from Overweight at Wells Fargo » 06:33
06/02/20
06/02
06:33
06/02/20
06:33
WAL

Western Alliance

$38.17 /

+0.05 (+0.13%)

Wells Fargo analyst Timur…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
WAL Western Alliance
$38.17 /

+0.05 (+0.13%)

WAL Western Alliance
$38.17 /

+0.05 (+0.13%)

04:47 Today Wells Fargo
Western Alliance downgraded to Equal Weight from Overweight at Wells Fargo
04/22/20 UBS
Western Alliance downgraded to Neutral from Buy at UBS
04/20/20 DA Davidson
Western Alliance price target raised to $42 from $34 at DA Davidson
03/06/20 SunTrust
SunTrust cuts price targets on Banks amid lower interest rate environment
WAL Western Alliance
$38.17 /

+0.05 (+0.13%)

WAL Western Alliance
$38.17 /

+0.05 (+0.13%)

WAL Western Alliance
$38.17 /

+0.05 (+0.13%)

Hot Stocks
Teleflex enrolls first patient for Teleflex's clinical study » 06:32
06/02/20
06/02
06:32
06/02/20
06:32
TFX

Teleflex

$365.99 /

+3.08 (+0.85%)

Teleflex announced the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TFX Teleflex
$365.99 /

+3.08 (+0.85%)

TFX Teleflex
$365.99 /

+3.08 (+0.85%)

05/01/20 Piper Sandler
Teleflex price target lowered to $375 from $425 at Piper Sandler
04/03/20 Raymond James
Teleflex price target lowered to $360 from $450 at Raymond James
02/20/20 Piper Sandler
Teleflex price target raised to $425 from $400 at Piper Sandler
12/12/19 Wells Fargo
SeaSpine, Glaukos double-downgraded to Underweight at Wells Fargo
TFX Teleflex
$365.99 /

+3.08 (+0.85%)

Syndicate
AudioCodes announces offering of 2.6M ordinary shares » 06:32
06/02/20
06/02
06:32
06/02/20
06:32
AUDC

AudioCodes

$38.08 /

+1.41 (+3.85%)

BofA Securities, Inc. and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AUDC AudioCodes
$38.08 /

+1.41 (+3.85%)

AUDC AudioCodes
$38.08 /

+1.41 (+3.85%)

04/14/20
AudioCodes downgraded to Hold at Needham on valuation and potential headwinds
04/14/20 Needham
AudioCodes downgraded to Hold from Buy at Needham
01/16/20 Sidoti
AudioCodes initiated with a Buy at Sidoti
07/23/19 Needham
AudioCodes price target raised to $20 from $16 at Needham
AUDC AudioCodes
$38.08 /

+1.41 (+3.85%)

AUDC AudioCodes
$38.08 /

+1.41 (+3.85%)

Downgrade
Triumph Bancorp downgraded to Underweight at Wells Fargo on valuation » 06:30
06/02/20
06/02
06:30
06/02/20
06:30
TBK

Triumph Bancorp

$24.37 /

-0.14 (-0.57%)

Wells Fargo analyst Jared…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TBK Triumph Bancorp
$24.37 /

-0.14 (-0.57%)

TBK Triumph Bancorp
$24.37 /

-0.14 (-0.57%)

04:47 Today Wells Fargo
Triumph Bancorp downgraded to Underweight from Equal Weight at Wells Fargo
04/22/20 Piper Sandler
Triumph Bancorp downgraded to Neutral from Overweight at Piper Sandler
03/17/20 Stephens
Triumph Bancorp upgraded to Overweight with $33 price target at Stephens
03/17/20 Stephens
Triumph Bancorp upgraded to Overweight from Equal Weight at Stephens
TBK Triumph Bancorp
$24.37 /

-0.14 (-0.57%)

Downgrade
Butterfield downgraded to Equal Weight from Overweight at Wells Fargo » 06:28
06/02/20
06/02
06:28
06/02/20
06:28
NTB

Butterfield

$24.27 /

-0.065 (-0.27%)

Wells Fargo analyst Timur…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NTB Butterfield
$24.27 /

-0.065 (-0.27%)

NTB Butterfield
$24.27 /

-0.065 (-0.27%)

04:47 Today Wells Fargo
Butterfield downgraded to Equal Weight from Overweight at Wells Fargo
05/04/20 Wells Fargo
Butterfield price target raised to $25 from $18 at Wells Fargo
04/01/20 Kansas City Capital
Butterfield upgraded to Outperform from Perform at Kansas City Capital
03/30/20 Wells Fargo
Butterfield upgraded to Overweight from Equal Weight at Wells Fargo
NTB Butterfield
$24.27 /

-0.065 (-0.27%)

Recommendations
Mr. Cooper price target raised to $15 from $12 at Piper Sandler » 06:28
06/02/20
06/02
06:28
06/02/20
06:28
COOP

Mr. Cooper

$11.27 /

+0.09 (+0.81%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COOP Mr. Cooper
$11.27 /

+0.09 (+0.81%)

COOP Mr. Cooper
$11.27 /

+0.09 (+0.81%)

05/15/20 Wedbush
Mr. Cooper upgraded to Outperform from Neutral at Wedbush
04/09/20 Piper Sandler
Mortgage Finance volatility brings 'unique opportunity,' says Piper Sandler
04/07/20 Wedbush
Mr. Cooper downgraded to Neutral at Wedbush
04/07/20 Wedbush
Mr. Cooper downgraded to Neutral from Outperform at Wedbush
COOP Mr. Cooper
$11.27 /

+0.09 (+0.81%)

COOP Mr. Cooper
$11.27 /

+0.09 (+0.81%)

Upgrade
Saint-Gobain upgraded to Overweight on stimulus benefits at JPMorgan » 06:23
06/02/20
06/02
06:23
06/02/20
06:23
CODYY

Saint-Gobain

$0.00 /

+ (+0.00%)

JPMorgan analyst Elodie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CODYY Saint-Gobain
$0.00 /

+ (+0.00%)

04:45 Today JPMorgan
Saint-Gobain upgraded to Overweight from Neutral at JPMorgan
05/29/20 DZ Bank
Saint-Gobain downgraded to Hold from Buy at DZ Bank
03/31/20 Jefferies
Saint-Gobain upgraded to Hold from Underperform at Jefferies
11/13/19 Jefferies
Continental Building buyout modest negative for Eagle Materials, says Jefferies
Periodicals
Emergency use of Gilead's remdesivir approved in India, Reuters reports » 06:22
06/02/20
06/02
06:22
06/02/20
06:22
GILD

Gilead

$75.15 /

-2.64 (-3.39%)

India's government…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GILD Gilead
$75.15 /

-2.64 (-3.39%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

06/01/20 Piper Sandler
Remdesivir now proven effective for COVID-19 in three studies, says Piper
05/27/20 Raymond James
Raymond James keeps Market Perform on Gilead following Arcus partnership
05/27/20 Wedbush
Arcus Biosciences price target raised to $48 from $40 at Wedbush
05/27/20 Piper Sandler
Piper says partnership more favorable for Gilead than outright Arcus purchase
GILD Gilead
$75.15 /

-2.64 (-3.39%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

GILD Gilead
$75.15 /

-2.64 (-3.39%)

Syndicate
Allogene Therapeutics 11.7M share Secondary priced at $47.00 » 06:21
06/02/20
06/02
06:21
06/02/20
06:21
ALLO

Allogene Therapeutics

$48.94 /

+0.86 (+1.79%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ALLO Allogene Therapeutics
$48.94 /

+0.86 (+1.79%)

ALLO Allogene Therapeutics
$48.94 /

+0.86 (+1.79%)

06/01/20
Fly Intel: Top five analyst downgrades
06/01/20 Oppenheimer
Allogene Therapeutics price target raised to $55 from $50 at Oppenheimer
06/01/20 Raymond James
Allogene Therapeutics downgraded to Market Perform from Outperform at Raymond James
06/01/20 Goldman Sachs
Allogene Therapeutics price target raised to $66 from $45 at Goldman Sachs
ALLO Allogene Therapeutics
$48.94 /

+0.86 (+1.79%)

  • 02
    Jun
ALLO Allogene Therapeutics
$48.94 /

+0.86 (+1.79%)

Recommendations
Western Union-Money Gram review could note more online competition, says BTIG » 06:21
06/02/20
06/02
06:21
06/02/20
06:21
WU

Western Union

$20.75 /

+0.72 (+3.59%)

, MGI

MoneyGram

$2.60 /

+0.185 (+7.66%)

, PYPL

PayPal

$154.51 /

-0.56 (-0.36%)

BTIG analyst Mark Palmer…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WU Western Union
$20.75 /

+0.72 (+3.59%)

MGI MoneyGram
$2.60 /

+0.185 (+7.66%)

PYPL PayPal
$154.51 /

-0.56 (-0.36%)

WU Western Union
$20.75 /

+0.72 (+3.59%)

04/08/20 Wells Fargo
Western Union downgraded to Underweight from Equal Weight at Wells Fargo
04/06/20 Barclays
Western Union price target lowered to $18 from $25 at Barclays
04/03/20 Northcoast
Northcoast cuts estimates for MoneyGram and Western Union
04/02/20 SunTrust
Western Union price target lowered to $18 from $27 at SunTrust
MGI MoneyGram
$2.60 /

+0.185 (+7.66%)

04/06/20 Barclays
MoneyGram price target lowered to $1 from $2 at Barclays
04/03/20 Northcoast
Northcoast cuts estimates for MoneyGram and Western Union
03/24/20 Northland
Northland downgrades MoneyGram to Market Perform on coronavirus lockdowns
03/24/20 Northland
MoneyGram downgraded to Market Perform from Outperform at Northland
PYPL PayPal
$154.51 /

-0.56 (-0.36%)

06/01/20 Wedbush
PayPal price target raised to $176 from $160 at Wedbush
05/28/20 RBC Capital
PayPal price target raised to $159 from $142 at RBC Capital
05/21/20 Bernstein
PayPal e-commerce growth, new users offset competition, says Bernstein
05/18/20 Stephens
PayPal price target raised to $159 from $132 at Stephens
WU Western Union
$20.75 /

+0.72 (+3.59%)

MGI MoneyGram
$2.60 /

+0.185 (+7.66%)

PYPL PayPal
$154.51 /

-0.56 (-0.36%)

WU Western Union
$20.75 /

+0.72 (+3.59%)

MGI MoneyGram
$2.60 /

+0.185 (+7.66%)

PYPL PayPal
$154.51 /

-0.56 (-0.36%)

WU Western Union
$20.75 /

+0.72 (+3.59%)

MGI MoneyGram
$2.60 /

+0.185 (+7.66%)

PYPL PayPal
$154.51 /

-0.56 (-0.36%)

WU Western Union
$20.75 /

+0.72 (+3.59%)

MGI MoneyGram
$2.60 /

+0.185 (+7.66%)

PYPL PayPal
$154.51 /

-0.56 (-0.36%)

Initiation
OCI NV initiated with an Underweight at JPMorgan » 06:20
06/02/20
06/02
06:20
06/02/20
06:20
OCINF

OCI NV

$0.00 /

+ (+0.00%)

JPMorgan analyst David…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OCINF OCI NV
$0.00 /

+ (+0.00%)

03/30/20 Morgan Stanley
OCI NV price target lowered to EUR 22 from EUR 25.70 at Morgan Stanley
Periodicals
Marriott seeing steady recovery in U.S., Reuters reports » 06:20
06/02/20
06/02
06:20
06/02/20
06:20
MAR

Marriott

$94.97 /

+6.49 (+7.33%)

Marriott has reopened all…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MAR Marriott
$94.97 /

+6.49 (+7.33%)

MAR Marriott
$94.97 /

+6.49 (+7.33%)

05/12/20 BMO Capital
Marriott price target raised to $74 from $65 at BMO Capital
05/12/20 Deutsche Bank
Marriott price target lowered to $88 from $124 at Deutsche Bank
05/12/20 Morgan Stanley
Marriott estimates cut at Morgan Stanley following Q1 report
04/22/20 BofA
Choice Hotels upgraded to Neutral from Underperform at Bofa
MAR Marriott
$94.97 /

+6.49 (+7.33%)

MAR Marriott
$94.97 /

+6.49 (+7.33%)

MAR Marriott
$94.97 /

+6.49 (+7.33%)

MAR Marriott
$94.97 /

+6.49 (+7.33%)

Syndicate
Guardant Health 11.5M share Spot Secondary priced at $84.00 » 06:19
06/02/20
06/02
06:19
06/02/20
06:19
GH

Guardant Health

$88.19 /

-2.22 (-2.46%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GH Guardant Health
$88.19 /

-2.22 (-2.46%)

GH Guardant Health
$88.19 /

-2.22 (-2.46%)

05/08/20 Citi
Guardant Health price target raised to $110 from $100 at Citi
04/23/20 SVB Leerink
Guardant Health price target lowered to $125 from $130 at SVB Leerink
03/11/20 JPMorgan
JPMorgan continues to recommend select exposure to Life Science Tools
02/21/20
Fly Intel: Top five analyst initiations
GH Guardant Health
$88.19 /

-2.22 (-2.46%)

  • 02
    Jun
GH Guardant Health
$88.19 /

-2.22 (-2.46%)

Syndicate
QTS Realty Trust 4.4M share Spot Secondary priced at $64.90 » 06:18
06/02/20
06/02
06:18
06/02/20
06:18
QTS

QTS Realty Trust

$67.45 /

-1.23 (-1.79%)

The deal size was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
QTS QTS Realty Trust
$67.45 /

-1.23 (-1.79%)

QTS QTS Realty Trust
$67.45 /

-1.23 (-1.79%)

05/04/20
Fly Intel: Top five analyst upgrades
05/04/20 Jefferies
QTS Realty Trust, CyrusOne upgraded to Buy on WFH boost at Jefferies
05/04/20 Jefferies
QTS Realty Trust upgraded to Buy from Hold at Jefferies
04/30/20 JPMorgan
QTS Realty Trust target raised to $70 on 'solid' Q1 at JPMorgan
QTS QTS Realty Trust
$67.45 /

-1.23 (-1.79%)

  • 02
    Jun
QTS QTS Realty Trust
$67.45 /

-1.23 (-1.79%)

Initiation
Melrose Industries initiated with an Equal Weight at Morgan Stanley » 06:17
06/02/20
06/02
06:17
06/02/20
06:17
MLSPF

Melrose Industries

$0.00 /

+ (+0.00%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MLSPF Melrose Industries
$0.00 /

+ (+0.00%)

04/26/20 Goldman Sachs
Melrose Industries downgraded to Neutral from Buy at Goldman Sachs
02/07/20 Goldman Sachs
Melrose Industries downgraded to Buy from Conviction Buy at Goldman Sachs
Syndicate
Carriage Services files $350M mixed securities shelf  06:17
06/02/20
06/02
06:17
06/02/20
06:17
CSV

Carriage Services

$18.40 /

-0.32 (-1.71%)

 
ShowHide Related Items >><<
CSV Carriage Services
$18.40 /

-0.32 (-1.71%)

CSV Carriage Services
$18.40 /

-0.32 (-1.71%)

05/20/20 Barrington
Carriage Services price target raised to $30 from $25 at Barrington
04/08/20 Barrington
Carriage Services recent weakness a buying opportunity, says Barrington
02/21/20 Barrington
Carriage Services to continue with improving organic growth, says Barrington
01/07/20 Barrington
Adtalem, Tivity, Virtusa among Barrington's Best Ideas for 2020
CSV Carriage Services
$18.40 /

-0.32 (-1.71%)

CSV Carriage Services
$18.40 /

-0.32 (-1.71%)

Syndicate
AudioCodes files automatic mixed securities shelf  06:16
06/02/20
06/02
06:16
06/02/20
06:16
AUDC

AudioCodes

$38.08 /

+1.41 (+3.85%)

 
ShowHide Related Items >><<
AUDC AudioCodes
$38.08 /

+1.41 (+3.85%)

AUDC AudioCodes
$38.08 /

+1.41 (+3.85%)

04/14/20
AudioCodes downgraded to Hold at Needham on valuation and potential headwinds
04/14/20 Needham
AudioCodes downgraded to Hold from Buy at Needham
01/16/20 Sidoti
AudioCodes initiated with a Buy at Sidoti
07/23/19 Needham
AudioCodes price target raised to $20 from $16 at Needham
AUDC AudioCodes
$38.08 /

+1.41 (+3.85%)

AUDC AudioCodes
$38.08 /

+1.41 (+3.85%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.